Life Sciences

Framingham State University will celebrate the opening of the university's new state-of-the-art science facility at a ceremony this afternoon.

Generex Biotechnology Corp., a Toronto company with operations in Worcester, has signed a letter of intent to pay $5 million to acquire a 51-percent stake in MediTemp Ltd.

Marlborough-based Boston Scientific Wednesday announced it is providing a new round of financing for MValve Technologies, which operates in Herzliya, Israel and San Diego.

A drug-delivering and self-dissolving arterial stent made by Boston Scientific has received Food and Drug Administration approval, the Marlborough-based company announced.

Two teams of researchers at the University of Massachusetts Medical School have studied a key step in HIV-1 infection — and their findings point to a possible way to fight the virus.

Hyundai Hope on Wheels has awarded the University of Massachusetts Medical School a $250,000 grant to fund childhood cancer research.

When it comes to making medicines, a Worcester Polytechnic Institute researcher is asking, “Can we do it better?” The National Institutes of Health has awarded the assistant professor and her team a $346,000 grant for a three-year project to find out.

SCIEX, a global life sciences and analytical technologies company based in Framingham, has announced that a novel form of cancer research technology from the company will be more commercially available through a deal with the Fred Hutchinson Cancer Research Center in Seattle, Wash.

The chairman of a Boston-based biomedical company was arrested Monday on federal charges of conspiracy and fraud stemming from an alleged scheme to inflate the company's stock prices, U.S. Attorney Carmen Ortiz announced.

Marlborough-based Sunovion Pharmaceuticals has extended a drug discovery and development agreement with a New York company.